ClinicalTrials.gg
Sign In

Infant, Premature, Diseases clinical trials

The registry lists 88 studies for Infant, Premature, Diseases across more than 10 countries. 11 are recruiting or about to start. 60 of them are mainly about Infant, Premature, Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 7 narrower conditions too, such as Bronchopulmonary Dysplasia: 808 studies, 163 open.

Get an email when these change. Save the Infant, Premature, Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
57
Status unknown
11
Recruiting
6
Terminated
4
Not yet recruiting
3
Active, not recruiting
3

Phase

Phase 3
6
Phase 2
6
Phase 1
4
Phase 4
1

Where

United States
22
Turkey
15
France
6
Switzerland
5
Spain
4
Canada
4

Who runs them

University of Zurich (4) · Kahramanmaras Sutcu Imam University (3) · Ondokuz Mayıs University (2) · Children's Hospital of Philadelphia (2) · Ain Shams University (2) · Leiden University Medical Center (2) · Duke University (2) · University of Virginia (2)

What is being tested here

Drugs under test in Infant, Premature, Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dobutamine101
Digoxin001
Poractant alfa001
Fish oil triglycerides011
Fish Oils011
Ranibizumab001
Lactobacillus reuteri001
Fentanyl011
Sevoflurane001
Vitamin D011

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 7 Infant, Premature, Diseases studies recruiting now, 2 (29%) set no upper age limit and 5 (71%) stop at 75 or younger. 7 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 7
AgeWomenMen
102 (29%)2 (29%)
182 (29%)2 (29%)
302 (29%)2 (29%)
402 (29%)2 (29%)
502 (29%)2 (29%)
652 (29%)2 (29%)
752 (29%)2 (29%)
852 (29%)2 (29%)

Across all 88 studies, recruiting or not: 84% stop at 75 or younger and 84% at 65; 100% take children; 3% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Infant, Premature, Diseases studies take

Of 33 interventional studies with no phase under Infant, Premature, Diseases, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase19 mo11–29 · 33 studies—19 mo11–29 · 33 studies
Observational12 mo6–22 · 16 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 88. Browse all 88 → or search them.